Global Impact

Global Impact

Subscribe
Coronavirus (Centers for Disease Control and Prevention)

Coronavirus

Novartis in Canada, including Sandoz Canada, initiates Community Strong COVID-19 response program

Coronavirus (Centers for Disease Control and Prevention)

Coronavirus disease (COVID-19) update

Novartis 2019 Financial Results

Alberta’s biosimilars policy: another significant step towards improving patient access to safe, effective, and high-quality medicines in Canada

Globe

Global Sandoz Press Release about biosimilar Erelzi®

Important update about the Boucherville plant and development center

Recall of Ranitidine medicines

Announcement about Avara

Important update about the Boucherville plant and development center acquired by Avara